SIGA Reiterates Expectation for New U.S. Contract Amid Slower Procurement

What happened

On its Q3 earnings call, SIGA Technologies stated it continues to expect a new U.S. government procurement contract for TPOXX, though timing remains uncertain after a slower-than-expected contracting process. This aligns with prior disclosures that most major options under the 19C BARDA contract are already exercised, leaving future domestic volumes discretionary. The company’s revenue remains heavily concentrated on U.S. government orders, making the timing and size of any successor contract a critical swing factor. While management’s posture suggests ongoing dialogue with BARDA, there is no contractual certainty and the process has clearly taken longer than hoped. Investors should view this as a cautious positive signal, but not a game changer until a formal award is announced.

Implication

The key driver remains whether a new procurement contract materializes on reasonable economics; without it, earnings will decline sharply after current deliveries. The balance sheet and dividend history provide some downside cushion, but the stock is ultimately a policy-dependent bet on U.S. biodefense spending. Long-term value creation will require diversifying revenue streams and securing recurring international orders.

Thesis delta

The thesis is unchanged in substance but may see a marginal increase in the probability of a successor contract given management’s continued expectation. However, the slower-than-expected contracting process underscores the discretionary nature of government procurement and should temper enthusiasm. The stance stays at 'Potential Buy' with the same watch item: a clear contract award on favorable terms would shift it toward BUY, while failure to secure would push toward SELL.